№ lp_2_2_05542
File format: docx Character count: 5999 File size: 45 KB
This document is a risk assessment report evaluating the application for authorisation of genetically modified maize MON-ØØ81Ø-6 for use in Ghana.
Year: 2024
Region / City: Ghana
Theme: Genetically Modified Organisms, Food Safety
Document Type: Risk Assessment Report
Organization: Technical Advisory Committee (TAC)
Author: Not specified
Target Audience: National Biosafety Authority, Regulatory Authorities
Period of Validity: 3 years
Approval Date: January 26, 2024
Date of Amendments: None
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Review of an application for authorisation of genetically modified maize (Zea mays) with OECD unique identifier MON-87411-9 for direct use as food, feed or for processing in Ghana submitted by Bayer West-Central Africa S.A.
Tracking No: 2023-229-BWCA-002-F
Date: January 26, 2024
Applicant: Bayer West-Central Africa S.A.
Organism: Maize (Zea mays)
Trait: Resistance to Coleoptera, Tolerance to Glyphosate
Genes: cp4 epsps, cry3Bb1, DvSnf7
Food and Feed Safety: Compositional considerations for Maize
Approval History: Argentina, Australia-New Zealand, Brazil, Canada, Colombia, European Union, Japan, Mexico, Paraguay, Philippines, Republic of Korea, USA, Vietnam
Date of First Approval: August 06, 2015 (Australia-New Zealand)
Assessment Summary: Safety and nutritional assessments confirm the event is as safe as its conventional counterpart.
Recommended Terms and Conditions: Limited to food, feed, and processing use; not for cultivation; compliance with biosafety regulations required.
Review of an application for authorisation of genetically modified soybean (Glycine max) with OECD unique identifier MON-877Ø5-6 for direct use as food, feed or for processing in Ghana submitted by Bayer West-Central Africa S.A.
Year: 2024
Region / city: Ghana
Topic: Genetically Modified Organisms, Soybean
Document Type: Risk Assessment Recommendation
Organisation: Technical Advisory Committee (TAC)
Author: Technical Advisory Committee (TAC)
Target Audience: National Biosafety Authority (NBA), Regulatory Authorities
Validity Period: 3 years, renewable
Approval Date: January 26, 2024
Date of Changes: N/A
Review of an application for authorisation of genetically modified maize (Zea mays) with OECD unique identifier MON-87411-9 for direct use as food, feed or for processing in Ghana submitted by Bayer West-Central Africa S.A.
Tracking No: 2023-229-BWCA-002-F
Date: January 26, 2024
Applicant: Bayer West-Central Africa S.A.
Organism: Maize (Zea mays)
Trait: Resistance to Coleoptera, Tolerance to Glyphosate
Genes: cp4 epsps, cry3Bb1, DvSnf7
Food and Feed Safety: Compositional considerations for Maize
Approval History: Argentina, Australia-New Zealand, Brazil, Canada, Colombia, European Union, Japan, Mexico, Paraguay, Philippines, Republic of Korea, USA, Vietnam
Date of First Approval: August 06, 2015 (Australia-New Zealand)
Assessment Summary: Safety and nutritional assessments confirm the event is as safe as its conventional counterpart.
Recommended Terms and Conditions: Limited to food, feed, and processing use; not for cultivation; compliance with biosafety regulations required.
RIVAROXABAN, TABLET 2.5 MG, XARELTO®, BAYER AUSTRALIA LIMITED
Year: 2023
Region / City: Australia
Topic: Pharmaceutical application for drug listing
Document Type: Submission for PBS listing
Organization / Institution: PBAC
Author: Bayer Australia Limited
Target Audience: Medical professionals and healthcare authorities
Period of Validity: Not specified
Approval Date: Not specified
Amendment Date: Not specified
Review of an application for authorisation of genetically modified soybean (Glycine max) with OECD unique identifier MON-877Ø5-6 for direct use as food, feed or for processing in Ghana submitted by Bayer West-Central Africa S.A.
Year: 2024
Region / city: Ghana
Topic: Genetically Modified Organisms, Soybean
Document Type: Risk Assessment Recommendation
Organisation: Technical Advisory Committee (TAC)
Author: Technical Advisory Committee (TAC)
Target Audience: National Biosafety Authority (NBA), Regulatory Authorities
Validity Period: 3 years, renewable
Approval Date: January 26, 2024
Date of Changes: N/A
Topics: MON-81-6 West-Central Bayer